QMA

Varex Imaging Corporation (VREX) — QMA analysis

Sector: Healthcare · Market cap: $592M · Price: $18.42 · Data as of 2026-10-23

62
/100
B
Composite grade
Higher score than 95% of 22,734 tracked stocks

Varex Imaging Corporation has an above-average composite score of 62/100, higher score than 95% of 22,734 tracked stocks. The highest-scoring layer is Earnings quality; the lowest is Insider activity.

Analytical score, not investment advice. No score is an instruction or a guarantee. Past performance ≠ future results.
Share this analysis
𝕏in

What 11 data layers say about VREX

The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.

LayerScore
Fundamental value (FVS)70/100
Earnings quality (EQS)93/100
Technical trend (TSS)51/100
Relative strength (RS)64/100
Momentum (USS)50/100
Insider activity (IAS)18/100
Off-exchange trading (FINRA) / large flows (WHS)58/100
Institutional 13F (IFS)63/100
News sentiment (NSS)61/100
Analysts / transcripts (ATS)46/100
Catalysts (XS)76/100

What does the QMA model currently show for Varex Imaging Corporation?

The composite score is an entry point, not a signal. What matters is layer confluence — whether they point the same direction.

For VREX the layers diverge — some score high (Earnings quality), others low (Insider activity). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.

VREX insider & smart money activity

Over the recent period we record 1 reported insider purchases and 5 sales for VREX: mixed picture. A description of the data layer, not an instruction.

VREX seasonality

The historically strong window for VREX was September 1–28 with a hit rate of 70% and an average move of 2.7% (10 years of history).

Historical data does not guarantee future results.

How VREX compares

Similar stocks from the same sector:

Frequently asked questions

What is the composite score for VREX stock?

62/100 (grade B) as of 2026-10-23, fusing 11 data layers. An analytical score, not advice.

Are insiders buying VREX stock?

Over the recent period, reported: purchases 1, sales 5 (purchases $2.19M, sales $4.76M). Insider activity: mixed picture — a description of reported data, not a trade instruction.

Where can I see live VREX data?

Live VREX data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.

Explore more — for free

The VREX score is just the start. Keep going free in the QMA magazine — analysis, tools and learning with no payment up front.

Free registration, no card — trial full access, then the free plan

Want the full VREX analysis with all layers and live data? Open VREX detail →

Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.

⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.

Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]